Genome-wide association study identifies new prostate cancer susceptibility loci.

Prostate cancer (PrCa) is the most common non-skin cancer diagnosed among males in developed countries and the second leading cause of cancer mortality, yet little is known regarding its etiology and factors that influence clinical outcome. Genome-wide association studies (GWAS) of PrCa have identified at least 30 distinct loci associated with small differences in risk. We conducted a GWAS in 2782 advanced PrCa cases (Gleason grade ≥ 8 or tumor stage C/D) and 4458 controls with 571 243 single nucleotide polymorphisms (SNPs). Based on in silico replication of 4679 SNPs (Stage 1, P < 0.02) in two published GWAS with 7358 PrCa cases and 6732 controls, we identified a new susceptibility locus associated with overall PrCa risk at 2q37.3 (rs2292884, P= 4.3 × 10(-8)). We also confirmed a locus suggested by an earlier GWAS at 12q13 (rs902774, P= 8.6 × 10(-9)). The estimated per-allele odds ratios for these loci (1.14 for rs2292884 and 1.17 for rs902774) did not differ between advanced and non-advanced PrCa (case-only test for heterogeneity P= 0.72 and P= 0.61, respectively). Further studies will be needed to assess whether these or other loci are differentially associated with PrCa subtypes.

[1]  Peter Kraft,et al.  Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. , 2011, Human molecular genetics.

[2]  Peter Kraft,et al.  Characterizing Associations and SNP-Environment Interactions for GWAS-Identified Prostate Cancer Risk Markers—Results from BPC3 , 2011, PloS one.

[3]  Hans Garmo,et al.  Radical prostatectomy versus watchful waiting in early prostate cancer. , 2005, The New England journal of medicine.

[4]  Peter Kraft,et al.  GWAS identifies a common breast cancer risk allele among BRCA1 carriers , 2010, Nature Genetics.

[5]  Yusuke Nakamura,et al.  Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population , 2010, Nature Genetics.

[6]  Nilanjan Chatterjee,et al.  Estimation of effect size distribution from genome-wide association studies and implications for future discoveries , 2010, Nature Genetics.

[7]  M. Thun,et al.  Refining the Prostate Cancer Genetic Association within the JAZF1 Gene on Chromosome 7p15.2 , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[8]  N. Sonenberg,et al.  Control of Cell Survival and Proliferation by Mammalian Eukaryotic Initiation Factor 4B , 2010, Molecular and Cellular Biology.

[9]  J. Carpten,et al.  Inherited genetic variant predisposes to aggressive but not indolent prostate cancer , 2010, Proceedings of the National Academy of Sciences.

[10]  Ali Amin Al Olama,et al.  Identification of seven new prostate cancer susceptibility loci through a genome-wide association study , 2009, Nature Genetics.

[11]  Ali Amin Al Olama,et al.  Multiple loci on 8q24 associated with prostate cancer susceptibility , 2009, Nature Genetics.

[12]  Kari Stefansson,et al.  Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility , 2009, Nature Genetics.

[13]  Peter Kraft,et al.  Identification of a new prostate cancer susceptibility locus on chromosome 8q24 , 2009, Nature Genetics.

[14]  J. Carpten,et al.  Two Independent Prostate Cancer Risk–Associated Loci at 11q13 , 2009, Cancer Epidemiology Biomarkers & Prevention.

[15]  S. Weinstein,et al.  Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility , 2009, Proceedings of the National Academy of Sciences.

[16]  J. Carpten,et al.  A novel prostate cancer susceptibility locus at 19q13. , 2009, Cancer research.

[17]  Jin Woo Kim,et al.  Sequence variants at 22q13 are associated with prostate cancer risk. , 2009, Cancer research.

[18]  Manuel A. R. Ferreira,et al.  Practical aspects of imputation-driven meta-analysis of genome-wide association studies. , 2008, Human molecular genetics.

[19]  J. Brooks.  Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer , 2008 .

[20]  R. Eeles,et al.  SNPs in the kallikrein gene region associated with prostate cancer risk: true cause or association by design? , 2008, Nature genetics.

[21]  M. Thun,et al.  Variation in KLK genes, prostate-specific antigen and risk of prostate cancer , 2008, Nature Genetics.

[22]  R. Eeles,et al.  Reply to “Variation in KLK genes, prostate-specific antigen and risk of prostate cancer” , 2008, Nature Genetics.

[23]  J. Carpten,et al.  Evidence for two independent prostate cancer risk–associated loci in the HNF1B gene at 17q12 , 2008, Nature Genetics.

[24]  K. Hemminki,et al.  Concordance of survival in family members with prostate cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Ali Amin Al Olama,et al.  Multiple newly identified loci associated with prostate cancer susceptibility , 2008, Nature Genetics.

[26]  W. Willett,et al.  Multiple loci identified in a genome-wide association study of prostate cancer , 2008, Nature Genetics.

[27]  J. Carpten,et al.  Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. , 2007, Journal of the National Cancer Institute.

[28]  Adam S. Kibel,et al.  A common variant associated with prostate cancer in European and African populations , 2007 .

[29]  D. Gudbjartsson,et al.  Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes , 2007, Nature Genetics.

[30]  D. Gudbjartsson,et al.  Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 , 2007, Nature Genetics.

[31]  P. Fearnhead,et al.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007, Nature Genetics.

[32]  K. Cooney,et al.  Genome‐wide linkage scan for prostate cancer aggressiveness loci using families from the University of Michigan Prostate Cancer Genetics Project , 2006, The Prostate.

[33]  P. Carroll,et al.  20-year outcomes following conservative management of clinically localized prostate cancer , 2005 .

[34]  J. Witte,et al.  Genome‐wide scan of brothers: Replication and fine mapping of prostate cancer susceptibility and aggressiveness loci , 2003, The Prostate.

[35]  A. Fischer,et al.  Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). , 2003, The Journal of clinical investigation.

[36]  Henrik Grönberg,et al.  Prostate cancer epidemiology , 2003, The Lancet.

[37]  D. Schaid,et al.  Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q. , 2003, American journal of human genetics.

[38]  M. Omary,et al.  The Intermediate Filament Protein Keratin 8 Is a Novel Cytoplasmic Substrate for c-Jun N-terminal Kinase* , 2002, The Journal of Biological Chemistry.

[39]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[40]  D V Conti,et al.  Genomewide scan for prostate cancer-aggressiveness loci. , 2000, American journal of human genetics.

[41]  W. Silvers.  The Coat Colors of Mice , 1979, Springer New York.